Pillstats
Rx only · Solution · Ophthalmic

Polymyxin B Sulfate And Trimethoprim

Polymyxin B Sulfate + Trimethoprim Sulfate

6 ACTIVE SUPPLIERS — US
openFDA · updated weekly
US6 NDCs
6 active makers
UKComing
soon
CAComing
soon
AUComing
soon
EUComing
soon
ATCA07AA05
RxCUI (US)8536
US makers6 labelers
Packages6
DEA / ScheduleNone

US acquisition costNADAC · per unit

Average across 1 priced NDCs. A benchmark of pharmacy acquisition cost — not a retail quote.

$0.137$0.273$0.410$0.547Dec 2025Apr 2026Jul 2026
$0.451
Latest avg · Jul 22, 2026
-5%
Since Dec 17, 2025
6
Active US suppliers
33%
Top-2 supplier share*

Medicaid dispensing volumeSDUD · per quarter

Prescriptions dispensed under Medicaid (fee-for-service + managed care), summed nationally. The closest free proxy to sales volume — Medicaid only, not all-payer.

81K162K244K325K2025 Q12025 Q22025 Q32025 Q42026 Q1
212K
Rx · 2026 Q1
2.1M
Units dispensed
-23%
Rx vs. year ago
5
Quarters · since 2025 Q1

Who makes it6 active · 0 exited

US labelers as registered with FDA. Repackagers relabel another company's product; share* is of listed packages, not sales.

LabelerTypePackagesStatus
Proficient Rx LPunknown1SUPPLYING
Sandoz Incunknown1SUPPLYING
A-S Medication Solutionsunknown1SUPPLYING
NuCare Pharmaceuticals, Inc.unknown1SUPPLYING
REMEDYREPACK INC.repackager1SUPPLYING
Preferred Pharmacetucials Inc.unknown1SUPPLYING

Regulatory & supply events

No recalls, shortages, or registration changes on record for this drug concept.